Sell Bio-Techne (TECH) stock to fund a goal

Calculator · free · no signup · TECH

Need cash for a goal? Plan the minimum-tax schedule to sell your vested Bio-Techne (TECH) shares and net a target amount by a target date, across tax years.

AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:Blacklight, August 2026 scan: zero trackersWebbkoll, August 2026 scan: no cookiesMDN HTTP Observatory grade, scanned live

Inputs

Your equity

One stack per ticker (current-employer RSUs, prior-employer holdings, index fund, etc.). Each stack has its own current price, growth assumption, and cost-basis lots.

Stack 1

Drives chance-of-shortfall · default 30%

Lots

Plan

Estimates only. Not financial advice.

10%
1%30%

Lock-in-now is deterministic (0%). Plans that wait depend on future prices; risk is near-zero when inventory comfortably exceeds the goal. Volatility: each stack's option-implied vol if a ticker is set, otherwise 30%. Lognormal model; real markets have fatter tails.

Tax
Wealth @ target$718,258$716,076$713,344$710,913
Chance of shortfall0%1.7%3.3%

Feasible

$400,027 net by 08/01/27

Total tax: $109,654 (federal $58,856, state $36,063, NIIT $14,736)

Schedule · Recommended

Sale dateSharesTaxNetCumulative
08/26/264,088$351,349$360,067
03/31/274$359$360,430
04/30/2732$2,891$363,340
05/31/27100$9,088$372,468
06/30/27100$9,141$381,631
07/31/27100$9,196$390,828
08/01/27100$9,199$400,027

Risk vs wealth

Each dot is a possible plan. Right is riskier, up is more wealth left over.

$710K$715K$719K0%5%10%chance of shortfall★your risk ceilingRecommendedLock in nowBalancedHold for growth

Trajectory of cash netted

Solid line = expected. Shaded band = 10th–90th percentile under price uncertainty.

$0$220K$440KAug 26Feb 27Aug 27goal $400K

After the plan

You keep 3,476 shares worth $410,758 at the projected target-date price, invested for the next decision.

You solved for a cash target. The beta optimizes your full portfolio across multiple goals and market scenarios, not just one funding need.

Request beta access →

Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator · RSU Sell-vs-Hold Calculator

About Bio-Techne

Bio-Techne (TECH) is a public Life Sciences company, incorporated in Minnesota and headquartered in Minneapolis, MN.

Last close: $72.47 per share (as of 2026-10-01).

Equity grants at Bio-Techne typically include restricted stock units (RSUs).

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

Source: Wikipedia (CC BY-SA 4.0)

Bio-Techne traces to 1976, when Roger Lucas founded Research and Diagnostic Systems (R&D Systems) in Minneapolis to sell blood-control samples for hematology labs; the company later renamed itself Bio-Techne and expanded into cytokines, antibodies, and RNAscope in situ hybridization reagents used by biotech researchers to visualize gene activity in tissue. It reported net sales above $1.2 billion for fiscal 2025 and employs roughly 2,900 people. On June 25, 2026, Germany's Merck KGaA agreed to acquire the company for $73 per share in cash, a deal valuing Bio-Techne's equity and debt combined (enterprise value) at about $11.3 billion.

Sources: investors.bio-techne.com · prnewswire.com · gurufocus.com · en.wikipedia.org

Equity comp at Bio-Techne

  • RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.

Researched 2026-08-17.

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Bio-Techne.

If you hold vested Bio-Techne (TECH) shares and need a set amount of cash by a date (a house down payment, tuition, a sabbatical, a business buy-in), the question is which lots to sell and in which tax years to keep the most after tax. This calculator builds the minimum-tax sell schedule across your lots, accounting for federal long-term capital gains, the net investment income tax, and your state.

Example: a 5,000-share TECH position at $72.47 is worth $362,350. Say you need $150,000 of it for a house down payment by next spring. Selling enough shares all in one tax year can push the gain into the higher long-term capital-gains bracket and trigger the 3.8% net investment income tax; spreading the sale across two tax years often nets more. The calculator above finds the minimum-tax sell schedule across your specific lots, basis, goal, and date.

All Bio-Techne tools → · Use the generic Stock Sale Funding Calculator for any company.

Bio-Techne equity questions

How much TECH stock do I sell to fund a goal without overpaying tax?
It depends on your cost basis, your target amount and date, and how the sale spreads across tax years. Selling vested TECH shares triggers long-term capital-gains tax, plus the 3.8% net investment income tax and state tax above certain income, and bunching a large sale into one year can push the gain into a higher bracket. The calculator above builds the minimum-tax sell schedule across your lots to net your target amount by your date.
Does Bio-Techne grant ISOs, NSOs, or RSUs?
Equity compensation at Bio-Techne typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
Do Bio-Techne RSUs use double-trigger vesting?
No. Bio-Techne restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyLife Sciences Tools peers

One piece of the puzzle.

OptionsAhoy plans your Bio-Techne equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access